SearcharxivSearch

arXiv subjects

Ruth H Keogh

Publications and source records attributed to Ruth H Keogh.

3 recordsLinked to original sources

The risks of risk assessment: causal blind spots when using prediction models for treatment decisions

Clinicians increasingly rely on prediction models to guide treatment choices. Most prediction models, however, are developed using observational data that include some patients who have already received the treatment the prediction model is meant to inform. Special attention to the causal role of those earlier treatments is required when interpreting the resulting predictions. We identify 'causal blind spots' in three common approaches to handling treatment when developing a prediction model: including treatment as a predictor, restricting to individuals taking a certain treatment, and ignoring treatment. Through several real examples, we illustrate how the risks obtained from models developed using such approaches may be misinterpreted and can lead to misinformed decision-making. Our discussion covers issues attributable to confounding, selection, mediation and changes in treatment protocols over time. We advocate for an extension of guidelines for the development, reporting and evaluation of prediction models to avoid such misinterpretations. Developers must ensure that the intended target population for the model, and the treatment conditions under which predictions hold, are clearly communicated. When prediction models are intended to inform treatment decisions, they need to provide estimates of risk under the specific treatment (or intervention) options being considered, known as 'prediction under interventions'. Next to suitable data, this requires causal reasoning and causal inference techniques during model development and evaluation. Being clear about what a given prediction model can and cannot be used for prevents misinformed treatment decisions and thereby prevents potential harm to patients.

stat.ME

A Bayesian location-scale joint model for time-to-event and multivariate longitudinal data with association based on within-individual variability

Within-individual variability of health indicators measured over time is becoming commonly used to inform about disease progression. Simple summary statistics (e.g. the standard deviation for each individual) are often used but they are not suited to account for time changes. In addition, when these summary statistics are used as covariates in a regression model for time-to-event outcomes, the estimates of the hazard ratios are subject to regression dilution. To overcome these issues, a joint model is built where the association between the time-to-event outcome and multivariate longitudinal markers is specified in terms of the within-individual variability of the latter. A mixed-effect location-scale model is used to analyse the longitudinal biomarkers, their within-individual variability and their correlation. The time to event is modelled using a proportional hazard regression model, with a flexible specification of the baseline hazard, and the information from the longitudinal biomarkers is shared as a function of the random effects. The model can be used to quantify within-individual variability for the longitudinal markers and their association with the time-to-event outcome. We show through a simulation study the performance of the model in comparison with the standard joint model with constant variance. The model is applied on a dataset of adult women from the UK cystic fibrosis registry, to evaluate the association between lung function, malnutrition and mortality.

stat.ME

Simulating data from marginal structural models for a survival time outcome

Marginal structural models (MSMs) are often used to estimate causal effects of treatments on survival time outcomes from observational data when time-dependent confounding may be present. They can be fitted using, e.g., inverse probability of treatment weighting (IPTW). It is important to evaluate the performance of statistical methods in different scenarios, and simulation studies are a key tool for such evaluations. In such simulation studies, it is common to generate data in such a way that the model of interest is correctly specified, but this is not always straightforward when the model of interest is for potential outcomes, as is an MSM. Methods have been proposed for simulating from MSMs for a survival outcome, but these methods impose restrictions on the data-generating mechanism. Here we propose a method that overcomes these restrictions. The MSM can be a marginal structural logistic model for a discrete survival time or a Cox or additive hazards MSM for a continuous survival time. The hazard of the potential survival time can be conditional on baseline covariates, and the treatment variable can be discrete or continuous. We illustrate the use of the proposed simulation algorithm by carrying out a brief simulation study. This study compares the coverage of confidence intervals calculated in two different ways for causal effect estimates obtained by fitting an MSM via IPTW.

stat.ME